Professional Documents
Culture Documents
'
- -
aa
Email : admin@aartidrugs.com
Website ; www.aartidruqs.com
crN NO : 137060MH1d'e+plcoss+::
Ref.: ADI,/Sry2f[:6-tz
Date: L2rh Augus t, 201.6
To,
Department of Corporate Service,
BSE Ltd.
Phiroze |eejeebhoy Towers,
Dalal Street, Mumbai _ 400 001.
BSE CODE - 524348
To,
Thanking you,
Yours faithfully,
For Aarti Drugs Limited
{,3
viur',;frilil
Company Secretary & Compliance
ffiD
Officer
.
Encl:
A/A
S;oN
t-
=t
CIN NO : 137060MH1984p1C055433
Press Release
Domestic market share for the key products has grown significantly over same
quarter
gf the previous year. Due to falling crude pricei, raw material and consequenfly the
finished goods selling prices havs shown u do*n*ard trend. This has led to raw
material inventory loss, adversely affecting the bottom-line, but it was partially
,
mitigated by the increased market rhur" to the extent of 17.21.% across its products.
Expanded capacities from the last year's expansion program have contributed
to
increased sales, which is evident in the number of units sold. Company
recently replied
to USFDA's request for information and is further upgrading its quailty systems,
with
the help of USFDA consultants.
Fol Aarti Drugs Limited
il
ud*#
Harshit M. Savla
Jt. Managing Director
DIN:00005340
Regd. Office : Plot No. N-19g, MIDC, Tarapur, Tal-palghar, Dist. Palghar 401 s06. (MH)